Maria Cherska: Exploring the Role of Fucoidan in Metabolic Liver Disease
Maria Cherska, The head of cardiology department at The State Institution «V.P. Komisarenko Institute of Endocrinology and Metabolism», shared a post on LinkedIn about a recent article by Xueru Chu et al., published in Lipids in Health and Disease։
“NAFLD/MASLD remains one of the most important cardiometabolic challenges worldwide – and this publication nicely highlights the role of oxidative stress and inflammation in disease progression.
A very interesting study recently published in Lipids in Health and Disease, demonstrated that fucoidan reduced lipid accumulation, oxidative stress, and NF-κB-mediated inflammation in a 3D NAFLD spheroid model through regulation of the PI3K/AKT/Nrf2 signaling pathway.
Particularly interesting:
- use of an advanced 3D spheroid NAFLD model;
- focus on oxidative stress and inflammatory pathways;
- potential future role of nutraceutical and functional food approaches in metabolic medicine.
Great to see this kind of translational and mechanistic research published in Lipids in Health and Disease – an important journal in the field of lipid metabolism, cardiometabolic diseases, and preventive medicine.”
Title: Fucoidan ameliorates lipid accumulation, oxidative stress, and NF-κB-mediated inflammation by regulating the PI3K/AKT/Nrf2 signaling pathway in a free fatty acid-induced NAFLD spheroid model
Authors: Xueru Chu, Xuan Wang, Keqing Feng, Yanzhen Bi, Yongning Xi, Shousheng Liu
Stay updated with Hemostasis Today.
-
May 20, 2026, 10:40Sameh Sayfo: Join Two Live Webinars on the New AHA Guidelines
-
May 20, 2026, 10:24How to Recognize Stroke Symptoms Instantly – Duke Health
-
May 20, 2026, 08:27Ahmed Koriesh: Persistent Delays, Higher Mortality, and Opportunities for Improvement for In-Hospital Stroke
-
May 20, 2026, 08:18ASH Launches Comprehensive Clinical Trial Learning Tool
-
May 20, 2026, 08:06Syed Mushahid Hussain: One of the Biggest Mistakes in CBC Interpretation is Analyzing Values in Isolation
-
May 20, 2026, 08:03Ann Marie O’Neill: Help Us Improve Information for DOAC Medicines
-
May 20, 2026, 08:03Tareq Abadl: Exploring the Clinical Power of Serum Protein Electrophoresis
-
May 20, 2026, 07:51Haroun Gajraj: Upto 30% of Patients Develop Brown Marks After Microsclerotherapy
-
May 20, 2026, 07:50Karen Schreiber: The BBQ Trial and the Challenge of Conducting Pregnancy RCTs